BioRestorative Therapies, Inc.
BRTX
$1.09
$0.010.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.34% | -183.12% | -121.20% | 13.81% | -34.20% |
| Total Depreciation and Amortization | 14.39% | 15.98% | 17.28% | 14.12% | 17.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.70% | 118.75% | 330.26% | -83.93% | 266.84% |
| Change in Net Operating Assets | 626.45% | 1,238.77% | 302.38% | -94.43% | 36.22% |
| Cash from Operations | -43.52% | -36.97% | -36.47% | -27.99% | -15.68% |
| Capital Expenditure | 70.21% | 8.45% | -28.58% | 37.86% | -14.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 960.21% | 464.04% | 293.76% | -81.87% | -496.58% |
| Cash from Investing | 828.09% | 438.12% | 285.27% | -84.18% | -1,284.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.02% | -78.30% | -89.03% | 220.50% | 235.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,013.90% | -466.37% | -917.89% | -- | -- |
| Cash from Financing | -76.21% | -80.36% | -90.34% | 214.18% | 234.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.91% | -261.57% | 110.01% | 59.43% | 75.98% |